Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-29

Clinical Trial Update: Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing nimesulide vs. CBD oil for pain in the preauricular region associated with temporomandibular joint disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CBD oil (cannabidiol oil)
  • nimesulide (nimesulide)

Snippet

Sponsor: Pomeranian Medical University Szczecin | Conditions: Temporomandibular Joint Disorders, Temporomandibular Joint Dysfunction Syndrome | Phase 2 | Status: UNKNOWN